Stock listing
Munich:5WK0 Aligos Therapeutics, Inc. Aktie
German listing (Munich) of Aligos Therapeutics, Inc. · home listing NASDAQ:ALGS
Follow Aligos Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ALGS
$4.84 USD -0.02 (-0.4%)
Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ALGS
- Day range
- $4.61 – $5.08 USDOct 19, 2026
- Volume
- 82,008 sharesOct 19, 2026
- Market cap
- $30.22M USDAt the close on Oct 19, 2026 · price × 6.24M shares outstanding
- 52-week range
- $3.98 – $13.69 USDLowest and highest trades, Oct 20, 2025 – Oct 19, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ALGS · Home | $4.84 USD | -0.02 (-0.4%) | 82,008 | $4.95 | $5.08 | $4.61 | $4.86 | Close on Oct 19, 2026 |
| Frankfurt:5WK0 | €4.205 EUR | -0.36 (-7.9%) | — | €4.30 | €4.30 | €4.205 | €4.565 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:ALGS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $4.84 | -0.02 | -0.4% | $4.95 | $5.08 | $4.61 | 82,008 | |
| $4.86 | -0.53 | -9.8% | $5.32 | $5.50 | $4.86 | 67,552 | |
| $5.39 | +0.16 | +3.1% | $5.40 | $5.409 | $5.186 | 25,467 | |
| $5.23 | -0.28 | -5.1% | $5.50 | $5.60 | $5.21 | 60,558 | |
| $5.51 | -0.02 | -0.4% | $5.465 | $5.60 | $5.20 | 34,000 | |
| $5.53 | +0.19 | +3.6% | $5.50 | $5.64 | $5.30 | 57,300 | |
| $5.34 | +0.03 | +0.6% | $5.27 | $5.442 | $5.27 | 8,900 | |
| $5.31 | -0.01 | -0.2% | $5.25 | $5.53 | $5.08 | 37,400 | |
| $5.32 | -0.06 | -1.1% | $5.33 | $5.525 | $5.23 | 19,400 | |
| $5.38 | -0.02 | -0.4% | $5.46 | $5.53 | $5.31 | 12,800 | |
| $5.40 | -0.14 | -2.5% | $5.57 | $5.65 | $5.35 | 48,600 | |
| $5.54 | +0.04 | +0.7% | $5.58 | $5.72 | $5.37 | 29,000 | |
| $5.50 | -0.13 | -2.3% | $5.69 | $5.74 | $5.367 | 28,300 | |
| $5.63 | +0.01 | +0.2% | $5.65 | $5.80 | $5.54 | 35,300 | |
| $5.62 | +0.08 | +1.4% | $5.53 | $5.68 | $5.40 | 11,500 | |
| $5.54 | +0.03 | +0.5% | $5.38 | $5.54 | $5.18 | 79,500 | |
| $5.51 | -0.04 | -0.7% | $5.70 | $5.765 | $5.47 | 45,000 | |
| $5.55 | -0.01 | -0.2% | $5.55 | $5.695 | $5.27 | 59,600 | |
| $5.56 | -0.12 | -2.1% | $5.72 | $5.936 | $5.45 | 35,100 | |
| $5.68 | +0.19 | +3.5% | $5.57 | $6.30 | $5.222 | 75,700 | |
| $5.49 | +0.25 | +4.8% | $5.31 | $5.88 | $5.21 | 125,000 | |
| $5.24 | +0.07 | +1.4% | $5.15 | $5.25 | $5.015 | 21,300 | |
| $5.17 | +0.12 | +2.4% | $5.10 | $5.29 | $5.10 | 21,700 | |
| $5.05 | +0.06 | +1.2% | $5.01 | $5.13 | $4.93 | 41,700 | |
| $4.99 | -0.05 | -1.0% | $5.04 | $5.445 | $4.82 | 34,100 | |
| $5.04 | -0.18 | -3.4% | $5.17 | $5.27 | $5.02 | 28,000 | |
| $5.22 | -0.11 | -2.1% | $5.39 | $5.502 | $5.14 | 37,000 | |
| $5.33 | -0.17 | -3.1% | $5.38 | $5.48 | $5.21 | 46,100 | |
| $5.50 | -0.26 | -4.5% | $5.79 | $6.02 | $5.41 | 33,000 | |
| $5.76 | -0.45 | -7.2% | $6.21 | $6.34 | $5.62 | 63,600 | |
| $6.21 | -0.01 | -0.2% | $6.16 | $6.21 | $6.02 | 20,300 | |
| $6.22 | +0.01 | +0.2% | $6.22 | $6.48 | $6.07 | 42,100 | |
| $6.21 | +0.12 | +2.0% | $6.15 | $6.64 | $6.01 | 55,200 | |
| $6.09 | +0.23 | +3.9% | $5.76 | $6.22 | $5.61 | 101,600 | |
| $5.86 | -1.05 | -15.2% | $6.83 | $6.83 | $5.86 | 98,700 | |
| $6.91 | -0.16 | -2.3% | $7.025 | $7.10 | $6.64 | 39,100 | |
| $7.07 | -0.44 | -5.9% | $7.44 | $7.495 | $6.82 | 80,300 | |
| $7.51 | +0.04 | +0.5% | $7.37 | $7.72 | $7.04 | 68,900 | |
| $7.47 | +0.54 | +7.8% | $6.93 | $7.538 | $6.71 | 93,400 | |
| $6.93 | +0.26 | +3.9% | $6.61 | $7.00 | $6.40 | 33,200 | |
| $6.67 | +0.23 | +3.6% | $6.48 | $6.799 | $6.40 | 52,300 | |
| $6.44 | -0.45 | -6.5% | $6.77 | $7.006 | $6.35 | 62,500 | |
| $6.89 | +0.13 | +1.9% | $6.74 | $7.085 | $6.67 | 77,300 | |
| $6.76 | +0.185 | +2.8% | $6.50 | $6.84 | $6.482 | 110,100 | |
| $6.575 | -0.315 | -4.6% | $6.90 | $7.00 | $6.51 | 50,600 | |
| $6.89 | +0.12 | +1.8% | $6.77 | $6.97 | $6.58 | 66,900 | |
| $6.77 | -0.23 | -3.3% | $6.95 | $7.04 | $6.66 | 95,200 | |
| $7.00 | -0.28 | -3.8% | $7.38 | $7.55 | $6.75 | 190,600 | |
| $7.28 | -0.37 | -4.8% | $7.58 | $7.82 | $7.15 | 237,700 | |
| $7.65 | +2.06 | +36.9% | $5.74 | $7.71 | $5.73 | 615,800 | |
| $5.59 | +0.08 | +1.5% | $5.50 | $6.15 | $5.25 | 335,800 | |
| $5.51 | +0.77 | +16.2% | $4.18 | $5.60 | $4.18 | 293,200 | |
| $4.74 | -0.01 | -0.2% | $4.74 | $4.87 | $4.67 | 71,800 | |
| $4.75 | +0.15 | +3.3% | $4.68 | $4.81 | $4.61 | 81,400 | |
| $4.60 | +0.37 | +8.7% | $4.29 | $4.805 | $4.21 | 135,000 | |
| $4.23 | -0.09 | -2.1% | $4.46 | $4.46 | $4.15 | 49,000 | |
| $4.32 | +0.07 | +1.6% | $4.30 | $4.49 | $4.13 | 98,900 | |
| $4.25 | 0.00 | 0.0% | $4.20 | $4.405 | $4.14 | 46,200 | |
| $4.25 | +0.17 | +4.2% | $4.22 | $4.37 | $3.98 | 87,500 | |
| $4.08 | 0.00 | 0.0% | $4.09 | $4.27 | $3.98 | 213,000 | |
| $4.08 | -0.61 | -13.0% | $4.80 | $4.805 | $4.00 | 203,100 | |
| $4.69 | -0.46 | -8.9% | $5.05 | $5.20 | $4.601 | 147,500 | |
| $5.15 | -0.29 | -5.3% | $5.36 | $5.50 | $5.08 | 58,500 | |
| $5.44 | +0.16 | +3.0% | $5.21 | $5.80 | $5.21 | 59,163 | |
| $5.28 | -0.46 | -8.0% | $5.72 | $5.72 | $5.19 | 85,817 |
- Ticker
- Munich:5WK0
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Oct 5, 2026
Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026
Latest news
Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026
Oct 5, 2026
Closed $5.38 (-0.4%) on Oct 6, 2026
Aligos Therapeutics to Present at the Cantor Global Healthcare Conference
Sep 2, 2026
Closed $6.21 (+2.0%) on Sep 2, 2026
Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China
Aug 12, 2026
Closed $6.77 (-3.3%) on Aug 13, 2026
Aligos Therapeutics to Announce 2nd Quarter 2026 Financial Results on August 6, 2026
Jul 30, 2026
Closed $4.32 (+1.6%) on Jul 30, 2026
Aligos Therapeutics Announces the Completion of Enrollment in the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium Under Development for the Treatment of Chronic HBV Infection
Jul 13, 2026
Closed $6.36 (-3.9%) on Jul 13, 2026
Aligos Therapeutics Receives Upfront Payment of $25M USD from the Exclusive License Deal of Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection
Jul 6, 2026
Closed $6.09 (+4.1%) on Jul 7, 2026
Aligos Therapeutics Presents Positive Data at the EASL Congress 2026
May 27, 2026
Closed $5.60 (-2.4%) on May 27, 2026
Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026
May 13, 2026
Closed $6.67 (+3.1%) on May 13, 2026
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results
May 7, 2026
Closed $6.44 (+6.8%) on May 8, 2026
Aligos Therapeutics to Announce 1st Quarter 2026 Financial Results on May 7, 2026
Apr 30, 2026
Closed $6.09 (+1.7%) on May 1, 2026
Decks
APASL 2025
Conference · 19 slides · March 2025
Technical Presentation (November 2024)
Technical · 19 slides · Nov 1, 2024
Investor Presentation (October 2024)
Investor deck · 43 slides · October 2024
Investor Presentation (June 2024)
Investor deck · 43 slides · June 2024
Aligos Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 24 in the last 12 months · 133 in all · newest Oct 5, 2026 · oldest 2020
- Decks
- 15 decks · latest March 2025
Where Aligos Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ALGS · Home listing | NASDAQ | United States | USD |
| BOATS:ALGS | BOATS | United States | USD |
| gettex:5WK0 | gettex | Germany | EUR |
| LS Exchange:A40LQ4 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A40LQ4 | Lang & Schwarz | Germany | EUR |
| Tradegate:5WK0 | Tradegate | Germany | EUR |
| Dusseldorf:5WK0 | Dusseldorf | Germany | EUR |
| Frankfurt:5WK0 | Frankfurt | Germany | EUR |
| Munich:5WK0 · This page | Munich | Germany | EUR |
| Stuttgart:5WK0 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Aligos Therapeutics, Inc.